KRYS
Price
$170.94
Change
-$7.19 (-4.04%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
5.13B
37 days until earnings call
VKTX
Price
$22.62
Change
-$1.60 (-6.61%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
2.72B
19 days until earnings call
Ad is loading...

KRYS vs VKTX

Header iconKRYS vs VKTX Comparison
Open Charts KRYS vs VKTXBanner chart's image
Krystal Biotech
Price$170.94
Change-$7.19 (-4.04%)
Volume$2.68K
Capitalization5.13B
Viking Therapeutics
Price$22.62
Change-$1.60 (-6.61%)
Volume$467.17K
Capitalization2.72B
KRYS vs VKTX Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. VKTX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Buy and VKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (KRYS: $178.13 vs. VKTX: $24.22)
Brand notoriety: KRYS and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 238% vs. VKTX: 100%
Market capitalization -- KRYS: $5.13B vs. VKTX: $2.72B
KRYS [@Biotechnology] is valued at $5.13B. VKTX’s [@Biotechnology] market capitalization is $2.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 3 bullish, 5 bearish.
  • VKTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than KRYS.

Price Growth

KRYS (@Biotechnology) experienced а -2.53% price change this week, while VKTX (@Biotechnology) price change was -7.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

KRYS is expected to report earnings on May 12, 2025.

VKTX is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($5.13B) has a higher market cap than VKTX($2.72B). KRYS YTD gains are higher at: 13.705 vs. VKTX (-39.811). KRYS has higher annual earnings (EBITDA): 110M vs. VKTX (-150.58M). VKTX has more cash in the bank: 903M vs. KRYS (598M). VKTX has less debt than KRYS: VKTX (1.12M) vs KRYS (7.26M). KRYS has higher revenues than VKTX: KRYS (291M) vs VKTX (0).
KRYSVKTXKRYS / VKTX
Capitalization5.13B2.72B189%
EBITDA110M-150.58M-73%
Gain YTD13.705-39.811-34%
P/E Ratio59.38N/A-
Revenue291M0-
Total Cash598M903M66%
Total Debt7.26M1.12M649%
FUNDAMENTALS RATINGS
KRYS vs VKTX: Fundamental Ratings
KRYS
VKTX
OUTLOOK RATING
1..100
7572
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
1973
SMR RATING
1..100
6793
PRICE GROWTH RATING
1..100
4793
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (44) in the Biotechnology industry is somewhat better than the same rating for KRYS (79) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew somewhat faster than KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (19) in the Pharmaceuticals Major industry is somewhat better than the same rating for VKTX (73) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VKTX’s over the last 12 months.

KRYS's SMR Rating (67) in the Pharmaceuticals Major industry is in the same range as VKTX (93) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VKTX’s over the last 12 months.

KRYS's Price Growth Rating (47) in the Pharmaceuticals Major industry is somewhat better than the same rating for VKTX (93) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VKTX’s over the last 12 months.

KRYS's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as VKTX (100) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSVKTX
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
76%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with KRYS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-5.69%
KRYS - VKTX
40%
Loosely correlated
-1.59%
ALT - VKTX
39%
Loosely correlated
-6.69%
CRNX - VKTX
38%
Loosely correlated
-8.03%
MREO - VKTX
38%
Loosely correlated
-6.75%
GPCR - VKTX
38%
Loosely correlated
-3.66%
More